WHO Prequalification of pneumococcal vaccine based on MRC Unit The Gambia study
Wednesday 5 October 2016
The World Health Organisation has pre-qualified Pfizer鈥檚 new four-dose, multi-dose vial (MDV) presentation of Prevenar 13庐*, based on the results of a study conducted by MRC Unit The Gambia (MRCG)